Ozempic Pills, Triple Agonists, 50% Weight Loss & Groundbreaking Peptides with Dr Spencer Nadolsky
Here’s a run down of what we discussed in today’s episode: GLP-1s, Peptides & Weight Loss Drugs Explained The Future of GLP-1s Beyond Weight Loss Could GLP-1s Treat Dementia & Other Diseases? The Next Generation of Weight Loss Peptides Retatrutide & Oral GLP-1s: What's Coming Next? The Biggest Risks of GLP-1…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Bite Back with Abbey Sharp
See all episodes →
Can GLP-1s Treat Eating Disorders? One Woman’s Controversial Story Is Challenging Everything
The SURPRISING Truth About Butter, Saturated Fat & Health (The Research SHOCKED Me!) | Fat Wars Part 2
Seed Oils, Inflammation & a Wellness Culture Lie | Fat Wars Part 1
Similar episodes from other shows
More like Bite Back with Abbey Sharp →
Ozempic & Weight Loss Drugs: Game Changers or Health Hazards?
619. GLP-1s and Your Thyroid: What Ozempic Is Really Doing to Your Hormones
GLP-1s & eating disorders: a complicated relationship
The Ozempic Revolution: The Future of Weight Management with Dr. Alexandra Sowa, Dual Board-Certified Physician, Author, and Founder
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.